Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 44Squamous Cell Carcinoma of Head and Neck 22Head and Neck Neoplasms 21Rectal Neoplasms 17Colonic Neoplasms 15Neoplasm Metastasis 13Neoplasms 12Carcinoma, Squamous Cell 10Carcinoma, Non-Small-Cell Lung 10Recurrence 5Pancreatic Neoplasms 5Esophageal Neoplasms 4Mouth Neoplasms 3Lung Neoplasms 3Laryngeal Neoplasms 3Laryngeal Diseases 3Breast Neoplasms 3Tongue Neoplasms 2Stomach Neoplasms 2Sarcoma 2Pharyngeal Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms, Squamous Cell 2Hereditary Sensory and Autonomic Neuropathies 2Glioma 2Glioblastoma 2Colorectal Cancer Metastatic 2Adenocarcinoma of Lung 2Adenocarcinoma Of Esophagus 2

Interventions

pembrolizumab 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Locally Advanced or Metastatic Solid Tumors × Cetuximab × Clear all
NCT05012618 2025-12-24

A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Chugai Pharmaceutical

Phase 1 Terminated
128 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡